GPER1 activation is now well-known for inducing protective effects in several disease models, including I/R injury, hypertension (4–6), Parkinson's disease (23), retinal ganglion degeneration (74), and breast cancer (75). This evidence concerns the gene GPER1 and breast carcinoma.